Company intelligence / Profile preview

Xention Ltd.

Pampisford/Cambridge/Newmarket* (*registered office), Cambridgeshire/Cambridge/East England, United Kingdomprnewswire.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Xention was a leading UK-based biotech focused on the discovery and development of ion channel-modulating small molecule drugs for cardiovascular and related disorders. Its most advanced asset was an IKur inhibitor for atrial fibrillation that reached Phase II trials with positive early results but appears to have been discontinued or outlicensed/spun out in recent years. The company also developed assets targeting overactive bladder, chronic cough, pain, autoimmune disease, and collaborated with major pharma partners.

Therapeutic areas: PulmonologyCardiovascularUrologyImmunologyNeurology
Modalities: Small molecules[3][5][9]
Industry: Biotech

Drug pipeline

1 asset

XEN-D0101

Discontinued

Partnerships

Servier (global except US/Japan rights to AF program)Grünenthal/Ono Pharmaceutical Co., Ltd. collaborations on pain therapeutics/ion channels.[3][5]

Beyond the preview

Go deeper on Xention Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xention Ltd..

Explore the full profile